Jornal SBC 189 | Abril 2018

SBC no Mundo Três trabalhos brasileiros foramapresentados no Late-Break- ing Clinical Trials do ACC.18: “ Carvedilol for Prevention of Chemotherapy-Induced Cardiotoxicity − Results of the Pro- spective, Randomized, Double Blind, Placebo-Controlled Ce- ccy Trial ”, de Mônica Ávila e Silvia Ayub-Ferreira e “ A Phase III, Randomized, International, Multicenter, Open label, with Blinded Adjudication of Outcomes, Non-Inferiority Clinical Tri- al to Explore the Safety and Efficacy of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome with ST Elevation Treated with Thrombolysis ” e “ Loading Doses of Atorvastatin versus Placebo in Patients with Acute Coronary Syndromes and Planned Revascularization: The SECURE-PCI Trial ”, ambos de Otávio Berwanger. Durante a apresentação, Mônica Ávila e Silvia Ayub- -Ferreira relataram as dificuldades em fazer pesquisas no Brasil sem quase nenhum apoio e pouquíssimo fi- nanciamento, apenas com a Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp). Os trabalhos podem ser conferidos nos links: http://ativsoftwa- re.com/appinfo.php?page=Session&project=ACC18&ser- ver =ep70.eventpilot.us &id=P41751, http://ativsoftware.com/ appinfo.php?page=Session&project=ACC18&server=ep70. eventpilot.us& id=P41745 e http://ativsoftware.com/appinfo. php?page=Session&project=ACC18&server=ep70.eventpi- lot.us &id=P41747W Trabalhos brasileiros são apresentados nos Late-Breaking Clinical Trials (e/d): Silvia Ayub-Ferreira e Mônica Ávila Otávio Berwanger Late Breaking Clinical Trials 24